What medication can be prescribed to manage Risperidone induced gynecomastia?

Aripiprazole is a partial agonist at dopamine D2 receptors and is known for its ability to modulate dopaminergic activity in the brain. In cases where patients experience side effects such as gynecomastia due to the use of antipsychotic medications like risperidone, switching to aripiprazole can be a beneficial strategy.

Risperidone has a higher propensity for hyperprolactinemia, which can lead to gynecomastia as a side effect. Aripiprazole, conversely, tends to have a more favorable profile regarding prolactin levels because of its partial agonist effects, which can mitigate the side effects associated with increased prolactin secretion.

Transitioning to aripiprazole often alleviates the undesirable side effects induced by risperidone without sacrificing the therapeutic benefits of antipsychotic treatment. This makes aripiprazole an appropriate choice for managing risperidone-induced gynecomastia, as it allows for continuity in treatment while addressing the side effect specifically.